EXAI BIO
Exai Bio is a next-generation liquid biospy company. Exai bio proprietary RNA and artificial intelligence-based liquid biopsy platform deliver clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.
EXAI BIO
Social Links:
Industry:
Biotechnology Health Diagnostics
Founded:
2021-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.exai.bio
Total Employee:
11+
Status:
Active
Total Funding:
67.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Domain Not Resolving Global Site Tag Amazon IPv6
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Employees Featured
Founder
Investors List
Section 32
Section 32 investment in Series A - Exai Bio
Casdin Capital
Casdin Capital investment in Series A - Exai Bio
Two Sigma Ventures
Two Sigma Ventures investment in Series A - Exai Bio
Official Site Inspections
http://www.exai.bio Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Exai Bio"
Exai Bio - Crunchbase Company Profile & Funding
Organization. Exai Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Exai Bio is an orphan non-coding RNAs and AI …See details»
Exai Bio 2025 Company Profile: Valuation, Funding
Exai Bio General Information Description. Developer of a liquid biopsy platform designed to accurately diagnose cancer and inform personalized care …See details»
Exai Bio Announces Publication in Nature Communications …
PALO ALTO, Calif., November 21, 2024--Exai Bio, a next-generation oncRNA- and generative AI-based liquid biopsy company, today announced a peer-reviewed publication about its …See details»
Our History | Exai
Exai brings together intrepid leaders in the fields of RNA biology, liquid biopsy, and artificial intelligence who are joining forces to fulfill our vision. ... Exai Bio Inc. 3350 west bayshore road palo alto, california 94303. quick links. Our …See details»
Exai Bio - Work in biotech
Exai Bio is advancing early cancer detection through the use of liquid biopsies. Early detection is the latest frontier in being able to effectively treat patients with cancer. Exai has built their next …See details»
Exai Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Last update 08 May 2025. Exai Bio, Inc. Startups | Holding Company | 2021 | California, United States |See details»
Exai Bio: Culture - LinkedIn
Exai Bio Biotechnology Research Palo Alto, California 5,358 followers Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cancer diagnosis.See details»
Exai Bio - Funding, Financials, Valuation & Investors - Crunchbase
Dec 9, 2021 Organization. Exai Bio . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 1. Total Funding Amount $67.5M. …See details»
Founder Spotlight #50: Pat Arensdorf @ Exai Bio
Aug 3, 2023 The disease has the “upper hand”. Exai Bio aims to solve this issue by developing blood tests that catch cancer not only at the earliest stages, but also the ability to detect the smallest tumors.See details»
Leadership | Exai
Exai Bio Inc. 3350 west bayshore road palo alto, california 94303. quick links. Our advantage. Leadership. ... By clicking "Accept All", you are agreeing to store cookies on your device to enhance your experience and help Exai's …See details»
Exai Bio - VentureRadar
Exai is developing liquid biopsy tests that detect a new class of cancer-associated small non-coding RNA biomarkers, termed orphan non-coding RNAs... ... Find out ...See details»
Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection …
Apr 18, 2023 Exai Bio is a next-generation liquid biopsy company. Its mission is to enable a world where cancer can be detected early, diagnosed accurately, treated in a personalized …See details»
Exai Bio - Contacts, Employees, Board Members, Advisors & Alumni
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the …See details»
Exai Bio Appoints Dave Daly as CEO to Lead Next-Gen Liquid …
Aug 1, 2024 Exai Bio's unique approach, combining oncRNA technology with generative AI, positions it at the forefront of liquid biopsy advancements. Daly's leadership is expected to …See details»
Our Performance | Exai
Exai’s research demonstrates the potential of oncRNAs for early detection of cancer. Our Science. Our Advantage Our Performance Our Publications. About Us. ... Exai Bio Inc. 3350 …See details»
News & Press - exai.bio
Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection Data at the American Association for Cancer Research (AACR) 2023 Annual Meeting Apr 2023 Exai Bio and …See details»
Exai Bio - Updates, News, Events, Signals & Triggers - Crunchbase
Exai Bio is focused on developing systems and methods for the detection and analysis of non-coding RNAs, particularly small RNA biomarkers, for early cancer detection. Their research …See details»
Our Advantage | Exai
Exai has shown that oncRNA patterns can be used to detect several types and subtypes of cancer, predict cancer tissue-of-origin and detect cancer at the earliest stages. In a study …See details»
Partnerships | Exai
Organization. your role. tell us more. interests. Learn about our clinical studies Interest in future studies and products Learn more about our RNA technology. ... Exai Bio Inc. 3350 west …See details»
Preparing for future AI capabilities in biology | OpenAI
6 days ago Advanced AI models have the power to rapidly accelerate scientific discovery, one of the many ways frontier AI models will benefit humanity. In biology, these models are already …See details»